<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>A1853</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>ASSEMBLY, No. 1853 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblywoman  SHANIQUE SPEIGHT</p>

<p class=bpuSponsor>District 29 (Essex and Hudson)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Requires all prescriptions be transmitted
electronically, subject to certain exceptions. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Introduced Pending Technical Review by Legislative
Counsel.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span>
concerning electronic prescriptions, amending various parts of the statutory
law, and supplementing Title 45 of the Revised Statutes.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      1.   Section
8 of P.L.1977, c.240 (C.24:6E-7) is amended to read as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      8.   Every
prescription blank shall be imprinted with the words, &quot;substitution
permissible&quot; and &quot;do not substitute&quot; and shall contain space for
the physician's or other authorized prescriber's initials next to the chosen
option<u>, and each prescription issued electronically using an electronic
health records system shall include a section for the physician or other
authorized prescriber to explicitly indicate that substitution is permissible
for that prescription or that substitution is not permissible for that
prescription</u>.  Notwithstanding any other law, unless the physician or other
authorized prescriber explicitly </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>states</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>indicates</u> that there shall be no
substitution when transmitting </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>an oral</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>a</u> prescription or, in the case of a written
prescription, indicates that there shall be no substitution by initialing the
prescription blank next to &quot;do not substitute,&quot; a different brand
name or nonbrand name drug product of the same established name shall be
dispensed by a pharmacist if such different brand name or nonbrand name drug
product shall reflect a lower cost to the consumer and is contained in the
latest list of interchangeable drug products published by the council; 
provided, however, where the prescriber indicates &quot;substitution
permissible, and requests the pharmacist to notify </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>him</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>the
prescriber</u> of the substitution,&quot; the pharmacist shall transmit notice,
either orally </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>or</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>,</u> by written notice to be <u>transmitted</u>
no later than the end of the business day <u>using an electronic health records
system, or by such other means as may authorized by the Director of the
Division of Consumer Affairs in the Department of Law and Public Safety</u>, to
the prescriber specifying the drug product actually dispensed and the name of
the manufacturer thereof.  However, no drug interchange shall be made unless a
savings to the consumer results, and the pharmacist passes such savings on to
the consumer in full by charging no more than the regular and customary retail
price for the drug to be substituted.  For prescriptions filled other than by
mail, the consumer may, if a substitution is indicated and prior to having </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>his</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>the
consumers</u> prescription filled, request the pharmacist or </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>his</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>the
pharmacists</u> agent to inform </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>him</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>the consumer</u> of the price savings that would
result from substitution.  If the consumer is not satisfied with said price
savings </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>he</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>the consumer</u> may, upon request, be dispensed
the drug product prescribed by the physician.  The pharmacist shall make a
notation of such request upon the prescription blank<u>, in the case of a
prescription issued using a New Jersey Prescription Blank, and in the patients
electronic health record, in the case of a prescription issued electronically
using an electronic health records system</u>.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.1977, c.240, s.8)</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      2.   Section
15 of P.L.1970, c.226 (C.24:21-15) is amended to read as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      15. 
Prescriptions.  a.  Except when dispensed directly in good faith by a
practitioner, other than a pharmacist, in the course of </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>his</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>the
practitioners</u> professional practice only, to an ultimate user, no
controlled dangerous substance included in Schedule II, which is a prescription
drug as defined in section 2 of P.L.2003, c.280 (C.45:14-41), may be dispensed
without </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>the written</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>a</u> prescription </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>of</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>issued by</u>
a practitioner </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>; provided
that in emergency situations, as prescribed by the division by regulation, such
drug may be dispensed upon oral prescription reduced promptly to writing and
filed by the pharmacist, if such oral prescription is authorized by federal law</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>in accordance with the requirements of section 8
of P.L.    , c.    (C.        ) (pending before the Legislature as this bill)</u>. 
Prescriptions shall be retained in conformity with the requirements of section
13 of P.L.1970, c.226 (C.24:21-13).  No prescription for a Schedule II
substance may be refilled.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.   Except
when dispensed directly in good faith by a practitioner, other than a
pharmacist, in the course of </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>his</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>the practitioners</u> professional practice
only, to an ultimate user, no controlled dangerous substance included in
Schedules III and IV which is a prescription drug as defined in section 2 of
P.L.2003, c.280 (C.45:14-41) may be dispensed without a </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>written or oral</span><b><span style='font-family:
"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> prescription <u>issued by a practitioner in
accordance with the requirements of section 8 of P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.    (C.        ) (pending before the Legislature as this bill)</u>.  Such
prescription may not be filled or refilled more than six months after the date
thereof or be refilled more than five times after the date of the prescription,
unless renewed by the practitioner.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      c.   No
controlled dangerous substance included in Schedule V may be distributed or
dispensed other than for a valid and accepted medical purpose.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      d.   A 
practitioner other than a veterinarian who prescribes a controlled dangerous
substance in good faith and in the course of </span><b><span style='font-family:
"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>his</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>the
practitioners</u> professional practice may administer the same or cause the
same to be administered by a nurse or intern under </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>his</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>the
practitioners</u> direction and supervision.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      e.   A
veterinarian who prescribes a controlled dangerous substance not for use by a
human being in good faith and in the course of </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>his</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>the
veterinarians</u> professional practice may administer the same or cause the
same to be administered by an assistant or orderly under </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>his</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>the
veterinarians</u> direction and supervision.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      f.    A
person who has obtained a controlled dangerous substance from the prescribing
practitioner for administration to a patient during the absence of the
practitioner shall return to the practitioner any unused portion of the
substance when it is no longer required by the patient or when its return is
requested by the practitioner.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      g.   Whenever
it appears to the division that a drug not considered to be a prescription drug
under existing State law should be so considered because of its abuse
potential, it shall so advise the New Jersey State Board of Pharmacy and
furnish to it all available data relevant thereto.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2007, c.244, s.14)</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      3.   Section
10 of P.L.1991, c.377 (C.45:11-49) is amended to read as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      10.
 a.  In addition to all other tasks which a registered professional nurse may,
by law, perform, an advanced practice nurse may manage preventive care services
and diagnose and manage deviations from wellness and long-term illnesses,
consistent with the needs of the patient and within the scope of practice of
the advanced practice nurse, by:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)  initiating
laboratory and other diagnostic tests;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)  prescribing
or ordering medications and devices, as authorized by subsections b. and c. of
this section; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)  prescribing
or ordering treatments, including referrals to other licensed health care
professionals, and performing specific procedures in accordance with the provisions
of this subsection.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.   An
advanced practice nurse may order medications and devices in the inpatient
setting, subject to the following conditions:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)  
the collaborating physician and advanced practice nurse shall address in the
joint protocols whether prior consultation with the collaborating physician is
required to initiate an order for a controlled dangerous substance;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)  
the order is written in accordance with standing orders or joint protocols
developed in agreement between a collaborating physician and the advanced
practice nurse, or pursuant to the specific direction of a physician;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)  
the advanced practice nurse authorizes the order by signing the nurse's own
name, printing the name and certification number, and printing the collaborating
physician's name;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4)  
the physician is present or readily available through electronic
communications;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (5) 
the charts and records of the patients treated by the advanced practice nurse
are reviewed by the collaborating physician and the advanced practice nurse
within the period of time specified by rules adopted by the Commissioner of
Health pursuant to section 13 of P.L.1991, c.377 (C.45:11-52);</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (6) 
the joint protocols developed by the collaborating physician and the advanced
practice nurse are reviewed, updated, and signed at least annually by both
parties; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (7) 
the advanced practice nurse has completed six contact hours of continuing
professional education in pharmacology related to controlled substances,
including pharmacologic therapy, addiction prevention and management, and
issues concerning prescription opioid drugs, including responsible prescribing
practices, alternatives to opioids for managing and treating pain, and the
risks and signs of opioid abuse, addiction, and diversion, in accordance with
regulations adopted by the New Jersey Board of Nursing.  The six contact hours
shall be in addition to New Jersey Board of Nursing pharmacology education
requirements for advanced practice nurses related to initial certification and
recertification of an advanced practice nurse as set forth in
N.J.A.C.13:37-7.2.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      c.   An
advanced practice nurse may prescribe medications and devices in all other
medically appropriate settings, subject to the following conditions:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)  the
collaborating physician and advanced practice nurse shall address in the joint
protocols whether prior consultation with the collaborating physician is
required to initiate a prescription for a controlled dangerous substance;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)  the
prescription is written in accordance with standing orders or joint protocols
developed in agreement between a collaborating physician and the advanced
practice nurse, or pursuant to the specific direction of a physician;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)  the
advanced practice nurse </span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>writes</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>issues</u> the prescription </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>on a New Jersey Prescription Blank pursuant to
P.L.2003, c.280 (C.45:14-40 et seq.)</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>in accordance with section 8 of P.L.&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill)</u>, signs the nurse's own name
to the prescription and </span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>prints</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>includes on the prescription</u> the nurse's
name and certification number;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4)  the
prescription is dated and includes the name of the patient and the name,
address, and telephone number of the collaborating physician;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (5)  the
physician is present or readily available through electronic communications;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (6)  the
charts and records of the patients treated by the advanced practice nurse are
periodically reviewed by the collaborating physician and the advanced practice
nurse;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (7)  the
joint protocols developed by the collaborating physician and the advanced
practice nurse are reviewed, updated, and signed at least annually by both
parties; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (8)  the
advanced practice nurse has completed six contact hours of continuing
professional education in pharmacology related to controlled substances,
including pharmacologic therapy, addiction prevention and management, and
issues concerning prescription opioid drugs, including responsible prescribing
practices, alternatives to opioids for managing and treating pain, and the
risks and signs of opioid abuse, addiction, and diversion, in accordance with
regulations adopted by the New Jersey Board of Nursing.  The six contact hours
shall be in addition to New Jersey Board of Nursing pharmacology education
requirements for advanced practice nurses related to initial certification and
recertification of an advanced practice nurse as set forth in
N.J.A.C.13:37-7.2.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      d.   The
joint protocols employed pursuant to subsections b. and c. of this section
shall conform with standards adopted by the Director of the Division of
Consumer Affairs pursuant to section 12 of P.L.1991, c.377 (C.45:11-51) or
section 10 of P.L.1999, c.85 (C.45:11-49.2), as applicable.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      e.   (Deleted
by amendment, P.L.2004, c.122.)</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      f.    An
attending advanced practice nurse may determine and certify the cause of death
of the nurse's patient and execute the death certification pursuant to
R.S.26:6-8 if no collaborating physician is available to do so and the nurse is
the patient's primary caregiver.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      g.   An
advanced practice nurse may authorize qualifying patients for the medical use
of cannabis and issue written instructions for medical cannabis to registered
qualifying patients, subject to the following conditions:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)  the
collaborating physician and advanced practice nurse shall address in the joint
protocols whether prior consultation with the collaborating physician is
required to authorize a qualifying patient for the medical use of cannabis or
issue written instructions for medical cannabis;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)  the
authorization for the medical use of cannabis or issuance of written
instructions for cannabis is in accordance with standing orders or joint
protocols developed in agreement between a collaborating physician and the
advanced practice nurse, or pursuant to the specific direction of a physician;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)  the
advanced practice nurse signs the nurse's own name to the authorization or
written instruction and prints the nurse's name and certification number;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4)  the
authorization or written instruction is dated and includes the name of the qualifying
patient and the name, address, and telephone number of the collaborating
physician;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (5)  the
physician is present or readily available through electronic communications;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (6)  the
charts and records of qualifying patients treated by the advanced practice
nurse are periodically reviewed by the collaborating physician and the advanced
practice nurse;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (7)  the
joint protocols developed by the collaborating physician and the advanced
practice nurse are reviewed, updated, and signed at least annually by both
parties; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (8)  the
advanced practice nurse complies with the requirements for authorizing
qualifying patients for the medical use of cannabis and for issuing written
instructions for medical cannabis established pursuant to P.L.2009, c.307
(C.24:6I-1 et al.).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2019, c.153, s.47)</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      4.   Section
16 of P.L.2003, c.280 (C.45:14-55) is amended to read as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      16. 
a.  </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>A</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'>  <u>Whenever a</u> practitioner practicing in this
State <u>issues a prescription for a controlled dangerous substance,
prescription legend drug, or other prescription item, the practitioner shall
issue the prescription electronically using an electronic health records
system, except that, if the prescription is not required to be transmitted by
electronic means under subsection b. of section 8 of P.L.&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill), the practitioner</u> shall </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>use</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>issue the
prescription using a</u> non-reproducible, non-erasable safety paper New Jersey
Prescription </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>Blanks</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>Blank</u> bearing that practitioner's license
number </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>whenever the
practitioner issues prescriptions for controlled dangerous substances,
prescription legend drugs or other prescription items</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>] </span></b><u><span
style='letter-spacing:0pt'>or in such other manner as may be authorized by the
Director of the Division of Consumer Affairs in the Department of Law and
Public Safety</span></u><span style='letter-spacing:0pt'>.  </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>The prescription</span><b><span style='font-family:
"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>Prescription</u> blanks shall be secured from a
vendor approved by the Division of Consumer Affairs in the Department of Law
and Public Safety.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.   A
licensed practitioner practicing in this State shall maintain a record of the
receipt of New Jersey Prescription Blanks.  The practitioner shall notify the
Office of Drug Control in the Division of Consumer Affairs as soon as possible
but no later than 72 hours of being made aware that any New Jersey Prescription
Blank in the practitioner's possession has been stolen.  Upon receipt of
notification, the Office of Drug Control shall take appropriate action,
including notification to the Department of Human Services and the Attorney
General.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2003, c.280, s.16)</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      5.   Section
17 of P.L.2003, c.280 (C.45:14-56) is amended to read as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      17.
 a.  Prescriptions issued by a health care facility licensed pursuant to
P.L.1971, c.136 (C.26:2H-1 et seq.) shall be <u>issued electronically using an
electronic health records system, except that, if the prescription is not
required to be transmitted by electronic means under subsection b. of section 8
of P.L.    , c.    (C.        ) (pending before the Legislature as this bill),
the prescription shall be</u> written on <u>a</u> non-reproducible,
non-erasable safety paper New Jersey Prescription </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>Blanks</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>Blank or
in such other manner as may be authorized by the Director of the Division of
Consumer Affairs in the Department of Law and Public Safety</u>.  </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>The prescription</span><b><span style='font-family:
"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>Prescription</u> blanks shall be secured from a
vendor approved by the Division of Consumer Affairs in the Department of Law
and Public Safety.  The New Jersey Prescription Blanks shall bear the unique
provider number assigned to that health care facility for the issuing of
prescriptions for controlled dangerous substances, prescription legend drugs or
other prescription items.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.   A
health care facility shall maintain a record of the receipt of New Jersey
Prescription Blanks.  The health care facility shall notify the Office of Drug
Control in the Division of Consumer Affairs as soon as possible but no later
than 72 hours of being made aware that any New Jersey Prescription Blank in the
facility's possession has been stolen.  Upon receipt of notification, the Office
of Drug Control shall take appropriate action including notification to the
Department of Human Services and the Attorney General.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2003, c.280, s.17)</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      6.   Section
18 of P.L.2003, c.280 (C.45:14-57) is amended to read as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      18. 
a.  A prescription issued by a practitioner or health care facility licensed in
New Jersey shall not be filled by a pharmacist unless the prescription is
issued <u>electronically using an electronic health records system, except
that, if the prescription that is not required to be transmitted by electronic
means under subsection b. of section 8 of P.L.    , c.    (C.        ) (pending
before the Legislature as this bill), the prescription shall not be filled by a
pharmacist unless the prescription is issued</u> on a New Jersey Prescription
Blank bearing the practitioner's license number or the unique provider number
assigned to a health care facility <u>or in such other manner as may be
authorized by the Director of the Division of Consumer Affairs in the
Department of Law and Public Safety</u>.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.   Notwithstanding
the provisions of subsection a. of this section to the contrary, a practitioner
or health care facility licensed in New Jersey may utilize an electronic health
record program to imprint the practitioner's name and license number or the
unique provider number assigned to a health care facility on a blank New Jersey
Prescription Blank for transmission to a pharmacist, provided that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)  any
other requirements under section 20 of P.L.2003, c.280 (C.45:14-59) and any
regulations adopted by the Director of the Division of Consumer Affairs in the
Department of Law and Public Safety concerning New Jersey Prescription Blanks
are met; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)  the
electronic health record program will imprint on the blank form all such
identifying information about the prescriber as </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>is
required by regulation of the Director of the Division of Consumer Affairs.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2009, c.297, s.1)</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     7.    Section 19 of P.L.2003,
c.280 (C.45:14-58) is amended to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     19.   a.  <b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>Nothing
contained in this act shall preclude a practitioner from transmitting to a
pharmacist by telephone or electronic means a prescription, as otherwise
authorized by law, if that practitioner provides the practitioner's Drug
Enforcement Administration registration number and the practitioner's license
number, or any other federally identified number, as appropriate, to the
pharmacist at the time the practitioner transmits the prescription.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>(Deleted
by amendment, P.L.    , c.    ) (pending before the Legislature as this bill)</u></p>

<p class=MsoNormal style='line-height:150%'>     b.    Except as may be
otherwise permitted by law, no prescription for any Schedule II controlled
dangerous substance shall be <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>given
or<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
transmitted to pharmacists, in any other manner, than in writing signed by the
practitioner <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>giving
or<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
transmitting the same <u>consistent with the requirements of section 8 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill)</u>, nor shall such prescription
be renewed or refilled.  The requirement in this subsection that a prescription
for any controlled dangerous substance be <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>given
or<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
transmitted to pharmacists in writing signed by the practitioner <u>consistent
with the requirements of section 8 of P.L.    , c.    (C.        ) (pending
before the Legislature as this bill)</u> shall not apply to a prescription for
a Schedule II drug if that prescription is transmitted or prepared in
compliance with federal and State regulations.</p>

<p class=MsoNormal style='line-height:150%'>     c.     (1)  Each vendor that
sells, leases, or licenses for use an electronic health records system that is
used to electronically transmit prescriptions in this State on the effective
date of P.L.2017, c.338 shall ensure that the system meets all federal
requirements for the system to accept, process, and transmit prescriptions for
Schedule II controlled dangerous substances no later than one year after the
effective date of P.L.2017, c.338 as a condition of continuing to  sell, lease,
or license for use the electronic health records system in this State.  Each
vendor that commences selling, leasing, or licensing for use an electronic health
records system that is used to electronically transmit prescriptions in this
State after the effective date of P.L.2017, c.338 shall ensure that the system
meets all federal requirements for the system to accept, process, and transmit
prescriptions for Schedule II controlled dangerous substances as a condition of
selling, leasing, or licensing for use the electronic health records system in
this State.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   The requirements of
paragraph (1) of this subsection shall not apply to a telemedicine or telehealth
organization, as that term is defined in section 1 of P.L.2017, c.117
(C.45:1-61), that exclusively provides telehealth and telemedicine services.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2017, c.338, s.1)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     8.    (New section)  a. 
Except as provided in subsections b. and c. of this section, no prescription
for a controlled dangerous substance, prescription legend drug, or other
prescription item shall be transmitted to a pharmacist by a practitioner in any
other manner than by electronic means using an electronic health records system.</p>

<p class=MsoNormal style='line-height:150%'>     b.    The requirement that a
prescription for a controlled dangerous substance, prescription legend drug, or
other prescription item be transmitted electronically using an electronic
health records system shall not apply to:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   a veterinarian;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   a practitioner
administering a controlled dangerous substance, prescription legend drug, or
other prescription item directly to a patient;</p>

<p class=MsoNormal style='line-height:150%'>     (3)   a practitioner
prescribing a controlled dangerous substance, prescription legend drug, or
other prescription item to be dispensed by an institutional pharmacy, as
defined in N.J.A.C.13:39-9.2;</p>

<p class=MsoNormal style='line-height:150%'>     (4)   a practitioner
prescribing a controlled dangerous substance, prescription legend drug, or
other prescription item to a patient under the care of a hospice;</p>

<p class=MsoNormal style='line-height:150%'>     (5)   a situation in which the
electronic prescribing system used by the practitioner is not operational or a
situation in which the system cannot be accessed by the practitioner due to a
temporary technological or electrical failure;</p>

<p class=MsoNormal style='line-height:150%'>     (6)   a situation in which the
patient requests the prescription be transmitted to a pharmacy that does not
possess the means to receive and process electronically transmitted
prescriptions; or</p>

<p class=MsoNormal style='line-height:150%'>     (7)   a practitioner who has
been granted a waiver due to technological limitations that are not reasonably
within the control of the practitioner, or other exceptional circumstances
demonstrated by the practitioner, pursuant to a process established in
regulation, and in the discretion of the Director of the Division of Consumer
Affairs in the Department of Law and Public Safety.</p>

<p class=MsoNormal style='line-height:150%'>     c.     If, pursuant to
subsection b. of this section, a prescription for a controlled dangerous
substance, prescription legend drug, or other prescription item is not required
to be transmitted electronically using an electronic health records system, the
prescription shall be issued on a New Jersey Prescription Blank or in such
other manner as may be authorized by the director.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     9.    (New section) The
Director of the Division of Consumer Affairs in the Department of Law and Public
Safety shall, pursuant to the Administrative Procedure Act, P.L.1968, c.410
(C.52:14B-1 et seq.), adopt rules and regulations as may be necessary to
implement the provisions of this act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     10.  This act shall take
effect one year after the date of enactment, except that the Director of the
Division of Consumer Affairs in the Department of Law and Public Safety may
take any administrative action in advance thereof as shall be necessary for the
implementation of this act.</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill requires that every
prescription for a controlled dangerous substance, prescription legend drug, or
other prescription item be transmitted electronically using an electronic
health records system.  This requirement will take effect one year after the
date of enactment.</p>

<p class=MsoNormal style='line-height:150%'>     The electronic prescription
requirement will not apply to:  a veterinarian; a practitioner administering a
prescription drug or item directly to a patient; a practitioner prescribing a
drug or item to be dispensed by an institutional pharmacy or to a patient in
hospice care; a situation in which the electronic prescribing system is not
operational or is temporarily inaccessible; a situation in which the patient
requests the prescription be transmitted to a pharmacy that is unable to
receive and process electronic prescriptions; or a practitioner who has been
granted a waiver due to technological limitations or other exceptional
circumstances.  A prescription that is subject to an exception would be issued
on a New Jersey Prescription Blank or in such other manner as may be authorized
by the Director of the Division of Consumer Affairs in the Department of Law
and Public Safety.</p>

<p class=MsoNormal style='line-height:150%'>     The bill revises various
provisions of the statutory law to reflect the mandatory electronic prescribing
requirement. </p>

</div>

</body>

</html>
